Analysis examines link between bone turnover markers and fracture risk in osteoporosis trials

Pooled data from 14 osteoporosis clinical trials of anti-resorptive drugs indicate that patients who have reduced levels of two bone turnover markers during treatment have lower risks of later experiencing vertebral fractures.

No were significantly associated with non-vertebral or hip fracture risks, according to the Journal of Bone and Mineral Research analysis.

The findings may be helpful in the development of anti-resorptive drugs for osteoporosis, particularly in choosing the dose and treatment schedule.


Explore further

Bone loss after denosumab, only partial protection with zoledronate

More information: Journal of Bone and Mineral Research (2018). DOI: 10.1002/jbmr.3355
Provided by Wiley
Citation: Analysis examines link between bone turnover markers and fracture risk in osteoporosis trials (2018, January 10) retrieved 22 August 2019 from https://medicalxpress.com/news/2018-01-analysis-link-bone-turnover-markers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more